Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 839.20
-1.30 (-0.15%)
Apr 24, 2025, 5:24 PM IDT
Oramed Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
340.59M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 60.26B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| Ilex Medical | 920.37M |
| BrainsWay | 149.39M |
| SofWave Medical | 217.27M |
Oramed Pharmaceuticals News
- 7 weeks ago - Oramed Pharmaceuticals Issues Letter to Shareholders - PRNewsWire
- 2 months ago - Congressional Trading Report: Rep. Brad Knott Sold Over $15K In Oramed Pharmaceuticals Stock - Benzinga
- 2 months ago - Oramed announces spinoff of protein drug technology - Seeking Alpha
- 2 months ago - Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin - PRNewsWire
- 7 months ago - Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt - PRNewsWire
- 10 months ago - Oramed Letter to Shareholders - PRNewsWire
- 10 months ago - Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock - PRNewsWire
- 1 year ago - Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company - PRNewsWire